Skip to main navigation Skip to search Skip to main content

Response to “Denosumab and Romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis”

  • Fang Lv
  • , Xiaoling Cai*
  • , Linong Ji
  • *Corresponding author for this work
  • Peking University

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number115271
JournalBone
Volume134
DOIs
Publication statusPublished - May 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this